【EFPIA】Medical Rationale Supporting Patient Access To Novel Oncology Combination Therapies.pdf

Considerations for the use of anthelminthic therapy for the treatment of neurocysticercosis

BioRestorative Therapies Inc 2024年度报告

Intra-Cellular Therapies Inc 2024年度报告

AK112 to validate its potential as next-generation IO therapy

Access to oncology combination therapies in Europe moving forward

Taysha Gene Therapies Inc 2024年度报告